- Home
- FENC vs CCRN Comparison
FENC vs CCRN Comparison
Compare FENC & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FENC | CCRN |
|---|---|---|
| Founded | 1996 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.3M | 270.9M |
| IPO Year | 2010 | 2001 |
Fundamental Metrics
Financial Performance| Metric | FENC | CCRN |
|---|---|---|
| Price | $7.55 | $9.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $15.00 | $13.15 |
| AVG Volume (30 Days) | 115.4K | ★ 538.7K |
| Earning Date | 01-01-0001 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.67 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $47,538,000.00 | ★ $816,484,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.78 | $4.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 123.69 | N/A |
| 52 Week Low | $4.68 | $7.43 |
| 52 Week High | $9.92 | $15.63 |
Technical Indicators
Market Signals| Indicator | FENC | CCRN |
|---|---|---|
| Relative Strength Index (RSI) | 39.52 | 53.85 |
| Support Level | $7.45 | $7.68 |
| Resistance Level | $8.27 | $9.40 |
| Average True Range (ATR) | 0.45 | 0.45 |
| MACD | -0.12 | 0.06 |
| Stochastic Oscillator | 10.51 | 43.90 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.